Intranasal Peptide Administration Protocol
Step-by-step protocol for intranasal peptide administration in research settings, covering nasal spray preparation, proper technique, dose volume considerations, and documentation for peptides commonly delivered via the nasal route.
Materials Needed
- Reconstituted peptide solution
- Sterile nasal spray bottle (metered-dose, typically 0.1 mL per spray)
- Alcohol swabs
- Saline solution (0.9% NaCl, sterile)
- Powder-free nitrile gloves
- Research log
Dosing Calculator
Calculate the injection volume needed for your target dose.
Result:
Injection Volume
0.100 mL
Syringe Units (U-100)
10.0 units
Doses Per Vial
20
Concentration: 2500 mcg/mL (2.50 mg/mL)
Verify Peptide Suitability for Intranasal Delivery
Confirm that the peptide being studied is appropriate for intranasal delivery. Peptides commonly administered intranasally in research include Selank, Semax, DSIP, and oxytocin — these have established nasal bioavailability data in the literature. Larger peptides (>5 kDa) generally have poor nasal absorption without permeation enhancers.
Tips
- • Review the monograph for your specific peptide to confirm intranasal delivery is supported by published research
- • Nasal delivery bypasses first-pass hepatic metabolism, which is advantageous for peptides degraded in the GI tract
Prepare the Nasal Spray Device
Use a sterile metered-dose nasal spray bottle calibrated to deliver a known volume per actuation (typically 0.1 mL per spray). Prime the spray device by pumping 3-5 times until a fine, consistent mist is produced. Discard any priming volume.
Estimated time: 2 minutes
Do not use spray devices that have been previously used for other solutions
Tips
- • Metered-dose sprays provide more consistent dosing than dropper bottles
- • Record the exact volume per actuation from the manufacturer's specifications
Calculate Dose and Spray Volume
Determine the number of sprays needed based on your peptide concentration and target dose. For example, if your reconstituted peptide is 1 mg/mL and the target dose is 200 mcg, and each spray delivers 0.1 mL, you need 2 sprays (0.1 mL x 2 = 0.2 mL = 200 mcg). Split the dose equally between nostrils when possible.
Tips
- • Use the dosing calculator below to determine exact spray counts
- • Typical intranasal research doses: Selank 250-500 mcg, Semax 200-600 mcg, DSIP 100-300 mcg
Clear Nasal Passages
Ensure nasal passages are clear before administration. Gentle saline irrigation or blowing the nose 5-10 minutes prior can improve mucosal contact. The nasal mucosa should be moist but not congested for optimal peptide absorption.
Estimated time: 2-5 minutes
Do not administer intranasally if there is active nasal bleeding or significant nasal congestion
Tips
- • Avoid using decongestant sprays within 30 minutes of peptide administration, as vasoconstrictors reduce mucosal absorption
Administer the Peptide
Tilt the head slightly forward (not back). Insert the spray nozzle just inside one nostril, angled slightly toward the outer wall (lateral direction, away from the septum). Close the opposite nostril with a finger. Actuate one spray while inhaling gently through the nose. Repeat in the other nostril if splitting the dose. Avoid sniffing forcefully — a gentle inhalation keeps the solution on the nasal mucosa rather than draining to the throat.
Estimated time: 1-2 minutes
Do not tilt the head backward — this causes drainage to the throat and reduces nasal absorption
Tips
- • Aiming toward the lateral wall improves contact with the highly vascularized respiratory epithelium
- • A gentle inhalation is sufficient — aggressive sniffing moves the solution past the absorptive surface
Post-Administration
Remain upright with the head in a neutral position for 2-3 minutes after administration. Avoid blowing the nose for at least 15 minutes. Avoid eating, drinking, or lying down for 10-15 minutes to minimize solution clearance from the nasal cavity.
Estimated time: 15 minutes
Tips
- • Some researchers apply gentle pressure to the nostrils for 10 seconds after spraying to enhance mucosal contact
Document and Store
Record the peptide name, dose, number of sprays per nostril, time of administration, and any observations. Store the nasal spray bottle at 2-8°C between uses. Note the reconstitution date — intranasal peptide solutions typically remain stable for 14-21 days when refrigerated.
Estimated time: 2 minutes
Tips
- • Label the spray bottle clearly with peptide name, concentration per spray, and reconstitution date
- • Keep a dedicated research log for intranasal protocols to track consistency across sessions
Related Monographs
Selank
An in-depth review of Selank, a synthetic tuftsin analog heptapeptide, covering its anxiolytic mechanisms, cognitive enhancement potential, GABA modulation, immunomodulatory properties, and key published research findings.
Read monographSemax
An in-depth review of Semax, a synthetic ACTH(4-10) analog, examining its nootropic properties, BDNF and NGF upregulation, neuroprotective mechanisms, and applications in cognitive enhancement research.
Read monographDSIP
A comprehensive review of Delta Sleep-Inducing Peptide (DSIP), a naturally occurring nonapeptide involved in sleep architecture modulation, circadian rhythm regulation, neuroendocrine function, stress adaptation, and antioxidant defense, including pharmacokinetics, safety profile, and dosing in research.
Read monographRelated Protocols
Cognitive Peptide Research Protocol
Research protocol for nootropic peptide compounds including Selank, Semax, and Dihexa, covering nasal and subcutaneous administration routes, cycling strategies, and cognitive assessment considerations.
Neuroprotective Peptide Research Protocol
Research protocol for studying neuroprotective peptides including Semax, Selank, and NAD+, covering their mechanisms in neuronal survival and neuroplasticity, dosing parameters, and cognitive assessment frameworks for neuroprotection research.
Oral Peptide Administration Protocol
Protocol for administering peptides via the oral route, covering compounds with established oral bioavailability (BPC-157, 5-Amino-1MQ, semaglutide), capsule handling, and timing considerations for gastrointestinal peptide delivery.
Peptide Laboratory Safety Protocol
Fundamental safety practices for handling research peptides, covering personal protective equipment, workspace setup, sharps disposal, spill management, and documentation requirements for safe peptide research.
